Search Results - "Sun, Leina"
-
1
Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review
Published in Frontiers in oncology (01-11-2023)“…Anaplastic lymphoma kinase gene (ALK) rearrangement is present in only approximately 5% of non-small cell lung cancers (NSCLCs) and is scarce in LCNEC…”
Get full text
Journal Article -
2
Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
Published in Journal for immunotherapy of cancer (01-11-2022)“…Tertiary lymphoid structures (TLS) existence is correlated with favorable prognosis in many types of cancer including non-small cell lung cancer (NSCLC)…”
Get full text
Journal Article -
3
CT‐based radiomics model to predict spread through air space in resectable lung cancer
Published in Cancer medicine (Malden, MA) (01-09-2023)“…Background Spread through air space (STAS) has been identified as a pathological pattern associated with lung cancer progression. Patients with STAS were…”
Get full text
Journal Article -
4
Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma
Published in Frontiers in immunology (31-01-2022)“…Immune checkpoint inhibitor-induced sarcoid-like reactions and tertiary lymphoid structures (TLSs) are increasingly recognized but rarely reported in the same…”
Get full text
Journal Article -
5
Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice
Published in Journal of experimental & clinical cancer research (17-03-2011)“…Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) have been widely used for the treatment of non-small cell lung cancer (NSCLC). KRAS and…”
Get full text
Journal Article -
6
Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma
Published in Frontiers in oncology (03-08-2022)“…Lung adenocarcinoma (LUAD) usually contains heterogeneous histological subtypes, among which the micropapillary (MIP) subtype was associated with poor…”
Get full text
Journal Article -
7
Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1‐ALK fusion
Published in Thoracic cancer (01-02-2022)“…The echinoderm microtubule associated protein‐like 4 gene (EML4) encodes the predominant anaplastic lymphoma kinase (ALK) fusion partner in non‐small‐cell lung…”
Get full text
Journal Article -
8
Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
Published in Oncotarget (20-06-2017)“…Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein encoded by a gene located in the short arm of chromosome 7. This study aimed to…”
Get full text
Journal Article -
9
A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation
Published in Cancer research and treatment (01-04-2021)“…A 61-year-old male patient was simultaneously diagnosed with lung adenocarcinoma and inflammatory myofibroblastic tumor (IMT). The lung adenocarcinoma and IMT…”
Get full text
Journal Article -
10
A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
Published in Cancer biology & medicine (01-05-2021)“…The immunoscore, which is used to quantify immune infiltrates, has greater relative prognostic value than tumor, node, and metastasis (TNM) stage and might…”
Get full text
Journal Article -
11
Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study
Published in Cancer communications (London, England) (01-09-2024)“…Background Anaplastic lymphoma kinase (ALK) test in advanced non‐small cell lung cancer (NSCLC) can help physicians provide target therapies for patients…”
Get full text
Journal Article -
12
Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression
Published in Zhongguo fei ai za zhi (20-02-2023)“…Small cell lung cancer (SCLC) with high c-Myc expression is prone to relapse and metastasis, leading to extremely low survival rate. Cyclin-dependent kinases 4…”
Get full text
Journal Article -
13
Meta-analysis of nifedipine and enalapril combination therapy for hypertensive patients with coronary heart disease
Published in Journal of medical biochemistry (02-11-2024)“…Background: Numerous clinical studies have demonstrated that the therapeutic efficacy of combining nifedipine and enalapril in treating hypertension with…”
Get full text
Journal Article -
14
MicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway
Published in Cell biochemistry and function (01-06-2018)“…More and more studies indicate the relevance of miRNAs in inducing certain drug resistance. Our study aimed to investigate whether microRNA‐130b‐3p (miR‐130b)…”
Get full text
Journal Article -
15
Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation
Published in Acta biochimica et biophysica Sinica (01-08-2018)“…Abstract One of the major obstacles hindering the treatment of lung cancer (LC) is chemoresistance; however, its mechanism remains unclear. The overexpression…”
Get full text
Journal Article -
16
A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy
Published in Lung cancer (Amsterdam, Netherlands) (01-04-2019)“…•Three testing methodologies (IHC, FISH, NGS) for ALK gene status in LSCC are compared•A realistic prevalence of the ALK rearrangement rate (0.17%) in LSCC is…”
Get full text
Journal Article -
17
Abemaciclib抑制c-Myc高表达小细胞肺癌增殖、侵袭和迁移的生物学功能的研究
Published in Zhongguo fei ai za zhi (20-02-2023)Get full text
Journal Article -
18
Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer
Published in Future oncology (London, England) (01-01-2017)“…As the prognostic value of the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) is unclear in patients with ALK-positive non-small-cell…”
Get full text
Journal Article -
19
Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma
Published in Molecular diagnosis & therapy (01-12-2011)“…Background and Objective: Signal transducer and activator of transcription (STAT) 3, a member of the STAT family of transcription factors in the Janus kinase…”
Get full text
Journal Article -
20
Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma
Published in Molecular diagnosis & therapy (01-12-2011)“…Background and Objective: Signal transducer and activator of transcription (STAT) 3, a member of the STAT family of transcription factors in the Janus kinase…”
Get full text
Journal Article